prokinetic drug

agent that promotes intestinal peristalsis.

[pro- + kinetic]

Mentioned in ?

References in periodicals archive ?

15) Another placebo controlled trial of the prokinetic drug, Itopride by Gerald Holtmann et al.

Randomized double blind placebo controlled trial to assess the efficacy and tolerability of levosulpiride in dysmotility type of functional dyspepsia

The herbal formula performed as well as the prokinetic drug for functional dyspepsia and was superior to metoclopramide in a retrospective cohort study of 961 patients.

SIBO: dysbiosis has a new name

Metoclopramide, a prokinetic drug used for more than 40 years to treat nausea and vomiting due to various causes, is one alternative to the doxylamine-pyridoxine combination.

Treating morning sickness

A randomised clinical trial comparing the efficacy of a herbal preparation STW5 with the prokinetic drug cisaprid in patients with dysmo-tility type of functional dyspepsia.

Synergy research: approaching a new generation of phytopharmaceuticals

Metoclopramide is another popular prokinetic drug that hastens stomach emptying of solid and liquid meals into the small intestines.

Non-acid gastroesophageal reflux and respiratory disorders: a literature review (1)

Peter Stein, Chairman and CEO of Norgine said, "There is a critical need for a new, safe and effective prokinetic drug for use in acute care settings, as there are no satisfactory treatments on the market.

Tranzyme Pharma and Norgine Sign License Agreement for Late-Stage Development Product, Ulimorelin (TZP-101), in Europe and Other Select Regions

VIRGINIA BEACH -- Don't bother trying to combine a prokinetic drug with a histamine type 2 receptor antagonist when a patient's gastroesophageal reflux disease proves to be treatment resistant, Dr.

Prokinetic Drugs, [H.sub.2] Blocker Ineffective on Hard-to-Treat GERD

each year, as well as for other indications in acute settings where an intravenous prokinetic drug is required.

Tranzyme Pharma Announces Issuance of Three New Patents Further Strengthening Company's Advanced Ghrelin Agonist Programs

The same study reported statistically significant benefits with the prokinetic drug cisapride, but there was evidence of a publication bias in these comparisons, making interpretation difficult ("positive" studies were more likely to be published than "negative" trials).

Treatment of Peptic Ulcer Disease and Nonulcer Dyspepsia

DDP733 is an oral prokinetic drug which Dynogen is developing as a treatment for both IBS-c and nocturnal gastroesophageal reflux disease (NGERD).

Dynogen Presents Results of Its Positive Phase 2a IBS-c Study with DDP733

TZP-102 is a second generation prokinetic drug that Tranzyme intends to develop for the treatment of mild-to-moderate gastroparesis and other chronic GI motility disorders.

Tranzyme Pharma Receives IND Clearance for Its Oral Ghrelin Agonist, TZP-102, for the Treatment of Gastroparesis

Efficacy was assessed after ruling out the impact of gastrointestinal prokinetic drugs.

Analysis of the Relationship between Helicobacter pylori Infection and Diabetic Gastroparesis

Full browser ?

CITE

Site: Follow: Share:

Open / Close